Neratinib: Extended Adjuvant Therapy, But When to Prescribe? Neratinib: Extended Adjuvant Therapy, But When to Prescribe?

The ExteNET study led to the approval of neratinib for extended adjuvant treatment of early-stage HER2+ breast cancer. But when should it be prescribed?Medscape Medical News
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news